1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Mediterranean Fish Vaccine Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Mediterranean Fish Vaccine Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Mediterranean Fish Vaccine Market Regional Analysis
6.2 Mediterranean Fish Vaccine Market Revenue 2020-2030 (US$ Million)
6.3 Mediterranean Fish Vaccine Market Forecast Analysis
7. Mediterranean Fish Vaccine Market Analysis – by Vaccine Type
7.1 Inactivated Vaccine
- 7.1.1 Overview
- 7.1.2 Inactivated Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Live-attenuated Vaccine
- 7.2.1 Overview
- 7.2.2 Live-attenuated Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Toxoid Vaccine
- 7.3.1 Overview
- 7.3.2 Toxoid Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Subunit Vaccine
- 7.4.1 Overview
- 7.4.2 Subunit Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.5 Conjugate Vaccine
- 7.5.1 Overview
- 7.5.2 Conjugate Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.6 Recombinant Vector Vaccine
- 7.6.1 Overview
- 7.6.2 Recombinant Vector Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Mediterranean Fish Vaccine Market Analysis – by Route of Administration
8.1 Immersion Vaccine
- 8.1.1 Overview
- 8.1.2 Immersion Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Injection Vaccine
- 8.2.1 Overview
- 8.2.2 Injection Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Oral Vaccine
- 8.3.1 Overview
- 8.3.2 Oral Vaccine: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Mediterranean Fish Vaccine Market Analysis – by Species
9.1 Turbot
- 9.1.1 Overview
- 9.1.2 Turbot: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 European Anchovy and Seabass
- 9.2.1 Overview
- 9.2.2 European Anchovy and Seabass: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Salmon
- 9.3.1 Overview
- 9.3.2 Salmon: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Mediterranean Sea Bass
- 9.4.1 Overview
- 9.4.2 Mediterranean Sea Bass: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.5 Common Dentex and Common Pandora
- 9.5.1 Overview
- 9.5.2 Common Dentex and Common Pandora: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.6 Sea Bream
- 9.6.1 Overview
- 9.6.2 Sea Bream: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.7 Rainbow Wrasse
- 9.7.1 Overview
- 9.7.2 Rainbow Wrasse: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.8 Sparus Aurata
- 9.8.1 Overview
- 9.8.2 Sparus Aurata: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.9 Trout
- 9.9.1 Overview
- 9.9.2 Trout: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.10 Mediterranean Swordfish and Bluefin Tuna
- 9.10.1 Overview
- 9.10.2 Mediterranean Swordfish and Bluefin Tuna: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.11 Grouper and Amberjack
- 9.11.1 Overview
- 9.11.2 Grouper and Amberjack: Mediterranean Fish Vaccine Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Mediterranean Fish Vaccine Market – Mediterranean Analysis
10.1 Overview
10.2 Mediterranean
- 10.2.1 Mediterranean Fish Vaccine Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.2.1.1 Mediterranean Fish Vaccine Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 Mediterranean:
Mediterranean Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 Mediterranean: Mediterranean Fish Vaccine Market Breakdown, by Vaccine Type
- 10.2.1.1.2 Mediterranean: Mediterranean Fish Vaccine Market Breakdown, by Route of Administration
- 10.2.1.1.3 Mediterranean: Mediterranean Fish Vaccine Market Breakdown, by Species
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Zoetis Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Merck & Co Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 HIPRA SA
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 ICTYODEV SAS
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Acuipharma Aquaculture Health SL
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Phibro Animal Health Corp
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Vaxxinova International BV
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Kyoto Biken Laboratories Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Elanco Animal Health Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Ceva SA
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations